Class IOngoing

Treprostinil Injection recall

FDA recall D-0429-2024 · initiated Mar 4, 2024

Most serious — a reasonable probability that use will cause serious harm or death.

Why it was recalled

Presence of Particulate Matter.

Details

Product: Treprostinil Injection, 20 mg/20 mL (1 mg/mL), For Subcutaneous or Intravenous Infusion Only, 20 mL Multiple-Dose Vial, Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977. NDC: 42023-206-01
Recalling company: Par Sterile Products
Classification: Class I
Status: Ongoing
Type: Voluntary: Firm initiated
Distribution: Nationwide in the USA
Initiated: Mar 4, 2024
FDA report date: Apr 3, 2024

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0429-2024 ↗

← All drug recalls